Found: 480
Select item for more details and to access through your institution.
Regulation of Drugs.
- Published in:
- 1973
- By:
- Publication type:
- Letter
Second allogeneic hematopoietic cell transplantation for graft failure: Poor outcomes for neutropenic graft failure.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 10, p. 892, doi. 10.1002/ajh.24111
- By:
- Publication type:
- Article
A cost-effectiveness approach to the qualification and acceptance of biomarkers.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 897, doi. 10.1038/nrd2174
- By:
- Publication type:
- Article
Characterizing heat mitigation strategies utilized by beef processors in the United States.
- Published in:
- Translational Animal Science, 2022, v. 6, n. 1, p. 1, doi. 10.1093/tas/txab231
- By:
- Publication type:
- Article
influence of Propionibacteria on in vivo rumen fermentation characteristics and in vitro lactic acid clearance rate in fistulated steers fed moderately high concentrate diets.
- Published in:
- Translational Animal Science, 2021, v. 5, p. S115, doi. 10.1093/tas/txab148
- By:
- Publication type:
- Article
Moving the needle for oncology dose optimization: A call for action.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 6, p. 909, doi. 10.1002/psp4.13157
- By:
- Publication type:
- Article
Surrogate endpoints in medicine.
- Published in:
- Disease Markers, 2002, v. 18, n. 2, p. 39, doi. 10.1155/2002/182186
- By:
- Publication type:
- Article
Overview of biomarkers and surrogate endpoints in drug development.
- Published in:
- Disease Markers, 2002, v. 18, n. 2, p. 41, doi. 10.1155/2002/929274
- By:
- Publication type:
- Article
Small and Smart: Why and How Smart City Solutions Can and Should be Adapted to the Unique Needs of Smaller Cities.
- Published in:
- New Global Studies, 2018, v. 12, n. 1, p. 21, doi. 10.1515/ngs-2018-0011
- By:
- Publication type:
- Article
What evidence do we need for biomarker qualification?
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 417, p. 1, doi. 10.1126/scitranslmed.aal4599
- By:
- Publication type:
- Article
A Phase I Trial of Sirolimus with "7&3" Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia.
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5129, doi. 10.3390/cancers15215129
- By:
- Publication type:
- Article
DIALOGUE.
- Published in:
- 1995
- By:
- Publication type:
- Editorial
PARTICIPATION'S EFFECTS ON PERFORMANCE AND SATISFACTION: A RECONSIDERATION OF RESEARCH EVIDENCE.
- Published in:
- Academy of Management Review, 1994, v. 19, n. 2, p. 312, doi. 10.5465/AMR.1994.9410210753
- By:
- Publication type:
- Article
The Organizational Double Bind: Toward an Understanding of Rationality and Its Complement.
- Published in:
- Academy of Management Review, 1978, v. 3, n. 4, p. 786, doi. 10.5465/AMR.1978.4289283
- By:
- Publication type:
- Article
An improved undergraduate mechanical engineering laboratory structure and curriculum: design and assessment.
- Published in:
- International Journal of Mechanical Engineering Education, 2012, v. 40, n. 3, p. 182, doi. 10.7227/IJMEE.40.3.3
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Anacetrapib in Black and White Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 12, p. 1578, doi. 10.1002/jcph.1287
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Anacetrapib Following Single Doses in Healthy, Young Japanese and White Male Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 2, p. 254, doi. 10.1002/jcph.1004
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, After Single and Multiple Doses in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 12, p. 1528, doi. 10.1002/jcph.773
- By:
- Publication type:
- Article
Effects of the orexin receptor antagonist suvorexant on respiration during sleep in healthy subjects.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 10, p. 1093, doi. 10.1002/jcph.523
- By:
- Publication type:
- Article
Lack of Meaningful Effect of Ridaforolimus on the Pharmacokinetics of Midazolam in Cancer Patients: Model Prediction and Clinical Confirmation.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 11, p. 1256, doi. 10.1002/jcph.331
- By:
- Publication type:
- Article
Prednisone Has No Effect on the Pharmacokinetics of CYP3A4 Metabolized Drugs - Midazolam and Odanacatib.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 11, p. 1280, doi. 10.1002/jcph.338
- By:
- Publication type:
- Article
Influence of Renal and Hepatic Impairment on the Pharmacokinetics of Anacetrapib.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 11, p. 1247, doi. 10.1002/jcph.320
- By:
- Publication type:
- Article
Single therapeutic and supratherapeutic doses of anacetrapib, a cholesteryl ester transfer protein inhibitor, do not prolong the QTcF interval in healthy volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 7, p. 765, doi. 10.1002/jcph.278
- By:
- Publication type:
- Article
Early-stage comparative effectiveness: Randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patients.
- Published in:
- Journal of Clinical Pharmacology, 2013, v. 53, n. 12, p. 1294, doi. 10.1002/jcph.182
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of MK-5046, a Bombesin Receptor Subtype-3 (BRS-3) Agonist, in Healthy Patients.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 9, p. 1306, doi. 10.1177/0091270011419854
- By:
- Publication type:
- Article
Effect of Different Durations and Formulations of Diltiazem on the Single-Dose Pharmacokinetics of Midazolam: How Long Do We Go?
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 11, p. 1561, doi. 10.1177/0091270010387141
- By:
- Publication type:
- Article
Clinical Pharmacology Profile of Raltegravir, an HIV-1 Integrase Strand Transfer Inhibitor.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 10, p. 1376, doi. 10.1177/0091270010387428
- By:
- Publication type:
- Article
Bioavailability of Alendronate and Vitamin D3 in an Alendronate/Vitamin D3 Combination Tablet.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 10, p. 1439, doi. 10.1177/0091270010382010
- By:
- Publication type:
- Article
Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Does Not Affect the Pharmacokinetics of Ethinyl Estradiol or Norethindrone in Healthy Female Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 9, p. 1319, doi. 10.1177/0091270010381497
- By:
- Publication type:
- Article
Lack of a Clinically Meaningful Pharmacokinetic Effect of Rifabutin on Raltegravir: In Vitro/In Vivo Correlation.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 6, p. 943, doi. 10.1177/0091270010375959
- By:
- Publication type:
- Article
Pharmacokinetics of Laropiprant, a Selective Prostaglandin D2 Receptor 1 Antagonist, in Patients With Moderate Hepatic Impairment.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 3, p. 406, doi. 10.1177/0091270010369240
- By:
- Publication type:
- Article
Effect of Diltiazem, a Moderate CYP3A Inhibitor, on the Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein Inhibitor, in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 3, p. 436, doi. 10.1177/0091270010368676
- By:
- Publication type:
- Article
Effect of Low-, Moderate-, and High-Fat Meals on Raltegravir Pharmacokinetics.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 3, p. 422, doi. 10.1177/0091270010367652
- By:
- Publication type:
- Article
Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 2, p. 202, doi. 10.1177/0091270010374853
- By:
- Publication type:
- Article
Effect of Raltegravir on the Pharmacokinetics of Methadone.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 12, p. 1461, doi. 10.1177/0091270009360981
- By:
- Publication type:
- Article
Single Therapeutic and Supratherapeutic Doses of Laropiprant, a Selective Prostaglandin D 2 Receptor 1 Antagonist, Do Not Prolong the QTcF Interval in Healthy Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 11, p. 1273, doi. 10.1177/0091270009360042
- By:
- Publication type:
- Article
Effects of Laropiprant, a Selective Prostaglandin D<sub>2</sub> Receptor 1 Antagonist, on the Steady-State Pharmacokinetics of Digoxin in Healthy Adult Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 7, p. 823, doi. 10.1177/0091270009356571
- By:
- Publication type:
- Article
PhRMA Survey on the Conduct of First-in-Human Clinical Trials Under Exploratory Investigational New Drug applications.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 4, p. 380, doi. 10.1177/0091270009344987
- By:
- Publication type:
- Article
Laropiprant in Combination With Extended- Release Niacin Does Not Alter Urine 11-Dehydrothromboxane B<sub>2</sub>, a Marker of In Vivo Platelet Function, in Healthy, Hypercholesterolemic, and Diabetic Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 12, p. 1426, doi. 10.1177/0091270009339593
- By:
- Publication type:
- Article
Multiple Doses of Sitagliptin, a Selective DPP-4 Inhibitor, Do Not Meaningfully Alter Pharmacokinetics and Pharmacodynamics of Warfarin.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 10, p. 1157, doi. 10.1177/0091270009341653
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability of Phentermine in Healthy Participants Receiving Taranabant, a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 10, p. 1228, doi. 10.1177/0091270009341651
- By:
- Publication type:
- Article
A Thorough QTc Study to Assess the Effect of Sitagliptin, a DPP4 Inhibitor, on Ventricular Repolarization in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 8, p. 937, doi. 10.1177/0091270009337511
- By:
- Publication type:
- Article
Single-Dose Administration of MK-0657, an NR2B-Selective NMDA Antagonist, Does Not Result in Clinically Meaningful Improvement in Motor Function in Patients With Moderate Parkinson's Disease.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 7, p. 856, doi. 10.1177/0091270009336735
- By:
- Publication type:
- Article
Effects of Aspirin When Added to the Prostaglandin D<sub>2</sub> Receptor Antagonist Laropiprant on Niacin-Induced Flushing Symptoms.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 4, p. 416, doi. 10.1177/0091270009332246
- By:
- Publication type:
- Article
Effect of Sitagliptin on the Pharmacokinetics of Simvastatin.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 4, p. 483, doi. 10.1177/0091270008330983
- By:
- Publication type:
- Article
Assessment of the CYP3A-Mediated Drug Interaction Potential of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 1, p. 80, doi. 10.1177/0091270008326718
- By:
- Publication type:
- Article
Influence of Taranabant, an Orally Active, Highly Selective, Potent Cannabinoid-1 Receptor (CB1R) Inverse Agonist, on Ethinyl Estradiol and Norelgestromin Plasma Pharmacokinetics.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 1, p. 72, doi. 10.1177/0091270008325930
- By:
- Publication type:
- Article
Lack of Erectogenic Activity of a Novel Selective Melanocortin-4 Receptor Agonist in a Clinical Experimental Model.
- Published in:
- Journal of Clinical Pharmacology, 2008, v. 48, n. 10, p. 1237, doi. 10.1177/0091270008320925
- By:
- Publication type:
- Article
Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX-2 Versus COX-1 in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2008, v. 48, n. 6, p. 745, doi. 10.1177/0091270008317590
- By:
- Publication type:
- Article
Effect of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Blood Pressure in Nondiabetic Patients With Mild to Moderate Hypertension.
- Published in:
- Journal of Clinical Pharmacology, 2008, v. 48, n. 5, p. 592, doi. 10.1177/0091270008316885
- By:
- Publication type:
- Article